A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 41,521 shares of BDX stock, worth $9.3 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
41,521
Previous 42,083 1.34%
Holding current value
$9.3 Million
Previous $10.4 Million 6.82%
% of portfolio
1.09%
Previous 1.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$225.07 - $246.17 $126,489 - $138,347
-562 Reduced 1.34%
41,521 $9.7 Million
Q1 2024

Apr 12, 2024

SELL
$233.45 - $247.73 $365,582 - $387,945
-1,566 Reduced 3.59%
42,083 $10.4 Million
Q4 2023

Feb 05, 2024

SELL
$232.24 - $267.23 $104,275 - $119,986
-449 Reduced 1.02%
43,649 $10.6 Million
Q3 2023

Oct 25, 2023

SELL
$254.9 - $283.59 $59,901 - $66,643
-235 Reduced 0.53%
44,098 $11.4 Million
Q2 2023

Jul 27, 2023

BUY
$238.39 - $265.32 $121,817 - $135,578
511 Added 1.17%
44,333 $11.7 Million
Q1 2023

Apr 28, 2023

SELL
$229.71 - $259.35 $147,473 - $166,502
-642 Reduced 1.44%
43,822 $10.8 Million
Q4 2022

Jan 30, 2023

SELL
$218.29 - $256.91 $89,280 - $105,076
-409 Reduced 0.91%
44,464 $11.3 Million
Q3 2022

Nov 01, 2022

SELL
$51.03 - $264.23 $35,874 - $185,753
-703 Reduced 1.54%
44,873 $10 Million
Q2 2022

Jul 15, 2022

SELL
$234.74 - $275.42 $94,600 - $110,994
-403 Reduced 0.88%
45,576 $11.2 Million
Q1 2022

Apr 27, 2022

BUY
$243.64 - $270.48 $3,654 - $4,057
15 Added 0.03%
45,979 $12.2 Million
Q4 2021

Feb 01, 2022

SELL
$230.08 - $250.94 $31,290 - $34,127
-136 Reduced 0.3%
45,964 $11.6 Million
Q3 2021

Oct 29, 2021

BUY
$232.72 - $256.47 $360,483 - $397,272
1,549 Added 3.48%
46,100 $11.3 Million
Q2 2021

Aug 09, 2021

BUY
$232.65 - $254.58 $294,302 - $322,043
1,265 Added 2.92%
44,551 $10.8 Million
Q1 2021

May 11, 2021

BUY
$232.09 - $256.88 $190,777 - $211,155
822 Added 1.94%
43,286 $10.5 Million
Q4 2020

Feb 05, 2021

SELL
$221.92 - $245.94 $2,441 - $2,705
-11 Reduced 0.03%
42,464 $10.6 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $61,062 - $78,323
283 Added 0.67%
42,475 $9.88 Million
Q2 2020

Aug 05, 2020

SELL
$219.9 - $263.41 $50,796 - $60,847
-231 Reduced 0.54%
42,192 $10.1 Million
Q1 2020

May 06, 2020

SELL
$195.69 - $279.01 $108,999 - $155,408
-557 Reduced 1.3%
42,423 $9.75 Million
Q4 2019

Feb 12, 2020

SELL
$236.45 - $266.82 $34,758 - $39,222
-147 Reduced 0.34%
42,980 $11.7 Million
Q3 2019

Nov 08, 2019

SELL
$230.58 - $256.08 $150,338 - $166,964
-652 Reduced 1.49%
43,127 $10.9 Million
Q2 2019

Aug 09, 2019

BUY
$217.4 - $246.08 $74,568 - $84,405
343 Added 0.79%
43,779 $11 Million
Q1 2019

May 07, 2019

SELL
$206.05 - $248.17 $23,489 - $28,291
-114 Reduced 0.26%
43,436 $10.8 Million
Q4 2018

Feb 12, 2019

BUY
$204.73 - $257.93 $6.91 Million - $8.7 Million
33,737 Added 343.8%
43,550 $9.81 Million
Q4 2018

Feb 11, 2019

SELL
$204.73 - $257.93 $6.83 Million - $8.6 Million
-33,357 Reduced 77.27%
9,813 $9.81 Million
Q3 2018

Nov 07, 2018

BUY
$233.07 - $256.0 $27,036 - $29,696
116 Added 0.27%
43,170 $11.3 Million
Q2 2018

Aug 08, 2018

BUY
$208.1 - $233.85 $9,156 - $10,289
44 Added 0.1%
43,054 $10.3 Million
Q1 2018

May 07, 2018

SELL
$205.46 - $240.27 $146,082 - $170,831
-711 Reduced 1.63%
43,010 $9.32 Million
Q4 2017

Feb 12, 2018

SELL
$189.0 - $222.64 $190,890 - $224,866
-1,010 Reduced 2.26%
43,721 $9.36 Million
Q3 2017

Nov 09, 2017

SELL
$186.89 - $198.9 $26,351 - $28,044
-141 Reduced 0.31%
44,731 $8.77 Million
Q2 2017

Aug 11, 2017

BUY
N/A
44,872
44,872 $8.76 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Folger Nolan Fleming Douglas Capital Management, Inc Portfolio

Follow Folger Nolan Fleming Douglas Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.